The Missoula Chronic Clinical Cannabis Use Study

[beachguy in thongs]

ABSTRACT.
The Missoula Chronic Clinical Cannabis Use Study was proposed to investigate the therapeutic bepnefits and adverse effects of prolonged use of â??medical marijuanaâ?� in a cohort of seriously ill patients. Use of cannabis was approved through the Compassionate Investigational New Drug (IND) program of the Food and Drug Administration (FDA). Cannabis is obtained from the National Institute on Drug Abuse (NIDA), and is utilized under the supervision of a study physician.

The aim of this study is to examine the overall health status of 4 of the 7 surviving patients in the program. This project provides the first opportunity to scrutinize the long-term effects of cannabis on patients who have used a known dosage of a standardized, heat-sterilized quality-controlled supply of low-grade marijuana for 11 to 27 years.

Results demonstrate clinical effectiveness in these patients in treating
glaucoma, chronic musculoskeletal pain, spasm and nausea, and spasticity
of multiple sclerosis. All 4 patients are stable with respect to their
chronic conditions, and are taking many fewer standard pharmaceuticals
than previously.

Mild changes in pulmonary function were observed in 2 patients,
while no functionally significant attributable sequelae were noted in any
other physiological system examined in the study, which included: MRI
scans of the brain, pulmonary function tests, chest X-ray, neuropsychological
tests, hormone and immunological assays, electroencephalography,
P300 testing, history, and neurological clinical examination.
These results would support the provision of clinical cannabis to a
greater number of patients in need. We believe that cannabis can be a
safe and effective medicine with various suggested improvements in the
existing Compassionate IND program. [Article copies available for a fee
from The Haworth Document Delivery Service: 1-800-HAWORTH. E-mail address:
<[email protected]> Website: <http://www.HaworthPress.
com>  2002 by The Haworth Press, Inc. All rights reserved.]

Complete Study can be found here: http://www.medicalcannabis.com/PDF/Chronic_Cannabis.pdf

Post anything.

beachguy in thongs Reviewed by beachguy in thongs on 04-23-2006. The Missoula Chronic Clinical Cannabis Use Study ABSTRACT. The Missoula Chronic Clinical Cannabis Use Study was proposed to investigate the therapeutic bepnefits and adverse effects of prolonged use of â??medical marijuanaâ?� in a cohort of seriously ill patients. Use of cannabis was approved through the Compassionate Investigational New Drug (IND) program of the Food and Drug Administration (FDA). Cannabis is obtained from the National Institute on Drug Abuse (NIDA), and is utilized under the supervision of a study physician. The aim of Rating: 5

[mrdevious]

I can't really see how a study would be taken seriously when only 4 subjects were involved. it seems a lot are, and 4 people simply aren't enough for a real study.

[beachguy in thongs]

Well, four people were studied for smoking pot for 11 to 27 years, and only two had slight pulmonary changes, every single other factor of their health remained the same.

That means that Cannabis goes 4 for 4. Did you see how extensive their tests were? If Cannabis was that bad, then at least 1 of the subjects would have turned out with ill-effects.

A study was done on Cannabis being bad for you, in the long-term, and all four subjects turned up healthy. Do that study with Heroin. With Cigarettes. Do it with foods, high in cholesterol.